KEAP1 and cancer: Notably, FSP1 specifically requires NADPH (not NADH) for its ferroptosis-suppressing function and is regulated by the Nrf2–Keap1 pathway, underscoring its therapeutic potential as a target in cancers resistant to ferroptosis [49,53,55].